Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman With Breast Cancer: A Case Report

Eleni M. Gamvroulas; Patricia Jeppson; Mei Wei

doi:10.12659/AJCR.949828

24 October 2025 : Case report USA

Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman With Breast Cancer: A Case Report

Unusual clinical course, Adverse events of drug therapy

Eleni M. Gamvroulas^{BDEF 1*}, Patricia Jeppson^{E 1}, Mei Wei

^{ADEF 2}

DOI: 10.12659/AJCR.949828

Am J Case Rep 2025; 26:e949828

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 A 38-year-old woman with infusion site extravasation injury following intravenous treatment with TDM1. Eight days after initial insult, her skin remains swollen and erythematous and shows further spread. She now has multiple closed blisters.

Back to the Article

Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman With Breast Cancer: A Case Report

Your Privacy